Furthermore, in a retrospective analysis of the FinHER trial, the B-cell attracting chemokine leukocyte chemoattractant–ligand (C–X–C motif) 13 (CXCL13) was independently associated with prognosis in triple-negative breast cancer. The gene discussed is CXCL13; the disease is triple-negative breast carcinoma.